Literature DB >> 27133953

The comparative oncologic effectiveness of available management strategies for clinically localized prostate cancer.

Mark D Tyson1, David F Penson2, Matthew J Resnick2.   

Abstract

The primary goal of modern prostate cancer treatment paradigms is to optimize the balance of predicted benefits associated with prostate cancer treatment against the predicted harms of therapy. However, given the limitations in the existing evidence as well as the significant tradeoffs posed by each treatment, there remain myriad challenges associated with individualized prostate cancer treatment decision-making. In this review, we summarize the existing comparative effectiveness evidence of treatments for localized prostate cancer with an emphasis on oncologic control. While we focus on the major treatment categories of radical prostatectomy, radiation therapy, and observation, we also provide a review of emerging therapies such as cryotherapy and high-intensity frequency ultrasound (HIFU).
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Active surveillance; Comparative effectiveness; Oncologic efficacy; Prostate cancer; Prostatectomy; Radiation therapy

Mesh:

Year:  2016        PMID: 27133953      PMCID: PMC5085892          DOI: 10.1016/j.urolonc.2016.03.021

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  72 in total

Review 1.  A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes.

Authors:  Stephen A Boorjian; James A Eastham; Markus Graefen; Bertrand Guillonneau; R Jeffrey Karnes; Judd W Moul; Edward M Schaeffer; Christian Stief; Kevin C Zorn
Journal:  Eur Urol       Date:  2011-12-07       Impact factor: 20.096

2.  A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.

Authors:  Koichiro Akakura; Hiroyoshi Suzuki; Tomohiko Ichikawa; Hiroyuki Fujimoto; Osamu Maeda; Michiyuki Usami; Daisaku Hirano; Yukie Takimoto; Toshiyuki Kamoto; Osamu Ogawa; Yoshiteru Sumiyoshi; Jun Shimazaki; Tadao Kakizoe
Journal:  Jpn J Clin Oncol       Date:  2006-11-02       Impact factor: 3.019

3.  Radical retropubic prostatectomy versus brachytherapy for low-risk prostatic cancer: a prospective study.

Authors:  C Giberti; L Chiono; Fabrizio Gallo; M Schenone; E Gastaldi
Journal:  World J Urol       Date:  2009-05-20       Impact factor: 4.226

4.  Characteristics of positive surgical margins in robotic-assisted radical prostatectomy, open retropubic radical prostatectomy, and laparoscopic radical prostatectomy: a comparative histopathologic study from a single academic center.

Authors:  Roula Albadine; Matthew E Hyndman; Alcides Chaux; J Y Jeong; Shahrazad Saab; Fabio Tavora; Jonathan I Epstein; Mark L Gonzalgo; Christian P Pavlovich; George J Netto
Journal:  Hum Pathol       Date:  2011-08-04       Impact factor: 3.466

5.  Patterns of Declining Use and the Adverse Effect of Primary Androgen Deprivation on All-cause Mortality in Elderly Men with Prostate Cancer.

Authors:  Jesse D Sammon; Firas Abdollah; Gally Reznor; Daniel Pucheril; Toni K Choueiri; Jim C Hu; Simon P Kim; Marianne Schmid; Akshay Sood; Maxine Sun; Adam S Kibel; Paul L Nguyen; Mani Menon; Quoc-Dien Trinh
Journal:  Eur Urol       Date:  2014-10-29       Impact factor: 20.096

6.  Hypofractionated intensity-modulated radiotherapy (70 gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes.

Authors:  Patrick A Kupelian; Vipul V Thakkar; Deepak Khuntia; Chandana A Reddy; Eric A Klein; Arul Mahadevan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-19       Impact factor: 7.038

7.  Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer.

Authors:  Stephen A Boorjian; R Jeffrey Karnes; Rosalia Viterbo; Laureano J Rangel; Eric J Bergstralh; Eric M Horwitz; Michael L Blute; Mark K Buyyounouski
Journal:  Cancer       Date:  2011-01-10       Impact factor: 6.860

8.  Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix.

Authors:  Michael J Zelefsky; James A Eastham; Angel M Cronin; Zvi Fuks; Zhigang Zhang; Yoshiya Yamada; Andrew Vickers; Peter T Scardino
Journal:  J Clin Oncol       Date:  2010-02-16       Impact factor: 44.544

9.  Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography.

Authors:  Albert Gelet; Jean Yves Chapelon; Laura Poissonnier; Raymonde Bouvier; Olivier Rouvière; Laura Curiel; Marc Janier; Guy Vallancien
Journal:  Urology       Date:  2004-04       Impact factor: 2.649

10.  Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer.

Authors:  Patrick A Kupelian; Louis Potters; Deepak Khuntia; Jay P Ciezki; Chandana A Reddy; Alwyn M Reuther; Thomas P Carlson; Eric A Klein
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-01-01       Impact factor: 7.038

View more
  5 in total

1.  Perioperative patient education improves long-term satisfaction rates of low-risk prostate cancer patients after radical prostatectomy.

Authors:  Alexander Kretschmer; Alexander Buchner; Markus Grabbert; Anne Sommer; Annika Herlemann; Christian G Stief; Ricarda M Bauer
Journal:  World J Urol       Date:  2017-01-16       Impact factor: 4.226

2.  Detection rate of PET/CT in patients with biochemical relapse of prostate cancer using [68Ga]PSMA I&T and comparison with published data of [68Ga]PSMA HBED-CC.

Authors:  Christoph Berliner; Milena Tienken; Thorsten Frenzel; Yuske Kobayashi; Annabelle Helberg; Uve Kirchner; Susanne Klutmann; Dirk Beyersdorff; Lars Budäus; Hans-Jürgen Wester; Janos Mester; Peter Bannas
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-11-28       Impact factor: 9.236

Review 3.  Therapeutic Ultrasound and Prostate Cancer.

Authors:  Karthik M Sundaram; Sam S Chang; David F Penson; Sandeep Arora
Journal:  Semin Intervent Radiol       Date:  2017-06-01       Impact factor: 1.513

4.  Multimodality Image Fusion with PSMA PET/CT and High-Intensity Focused Ultrasound Focal Therapy for Primary Diagnosis and Management of Prostate Cancer: A Planned Research Initiative.

Authors:  Marcia C Javitt; Alexander Kravtsov; Zohar Keidar; Sobhi Abadi; Gilad E Amiel
Journal:  Rambam Maimonides Med J       Date:  2017-10-16

5.  Adherence to Report and Patient Perception of an Interactive App for Managing Symptoms During Radiotherapy for Prostate Cancer: Descriptive Study of Logged and Interview Data.

Authors:  Ann Langius-Eklöf; Mats Christiansen; Veronica Lindström; Karin Blomberg; Maria Hälleberg Nyman; Yvonne Wengström; Kay Sundberg
Journal:  JMIR Cancer       Date:  2017-10-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.